Geoff Meacham
Stock Analyst at Citi
(4.81)
# 446
Out of 5,053 analysts
1227
Total ratings
57%
Success rate
13.5%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMY Bristol-Myers Squibb Company | Reiterated: Hold | $70 | $56.67 | +23.52% | 75 | Oct 13, 2026 | |
| BNTX BioNTech SE | Reiterated: Buy | $125 | $89.01 | +40.43% | 18 | Oct 13, 2026 | |
| MRK Merck & Co. | Reiterated: Hold | $125 → $145 | $141.98 | +2.13% | 67 | Oct 13, 2026 | |
| PFE Pfizer | Reiterated: Hold | $27 | $28.37 | -4.83% | 77 | Oct 13, 2026 | |
| ABBV AbbVie | Reiterated: Hold | $260 | $274.36 | -5.23% | 69 | Oct 12, 2026 | |
| AMGN Amgen | Reiterated: Hold | $405 | $412.84 | -1.90% | 49 | Oct 12, 2026 | |
| BIIB Biogen | Reiterated: Hold | $215 | $228.90 | -6.07% | 74 | Oct 12, 2026 | |
| GILD Gilead Sciences | Reiterated: Buy | $165 | $147.92 | +11.55% | 82 | Oct 12, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Buy | $1,600 | $1,166.51 | +37.16% | 101 | Oct 12, 2026 | |
| REGN Regeneron Pharmaceuticals | Reiterated: Hold | $740 | $753.12 | -1.74% | 63 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $56.57 | +23.74% | 29 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $585 | $485.22 | +20.56% | 69 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 → $150 | $106.68 | +40.61% | 20 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $325 | $210.39 | +54.48% | 1 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $60 → $80 | $216.25 | -63.01% | 63 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $4.72 | +154.24% | 1 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $5 | $1.82 | +175.48% | 12 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 | $116.26 | +37.62% | 11 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $74 | $40.52 | +82.63% | 7 | Sep 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $182 | $138.49 | +31.42% | 14 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $19.06 | +162.33% | 4 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $32 | $26.85 | +19.18% | 21 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $100 | $78.53 | +27.34% | 18 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $21.51 | +155.70% | 3 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $7 | $12.82 | -45.40% | 7 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $75 | $59.92 | +25.17% | 16 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $20.19 | +172.41% | 4 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $170 | $248.61 | n/a | 33 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $0.3702 | n/a | 3 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $54.38 | n/a | 35 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $0.47 | n/a | 8 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $50.10 | n/a | 8 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $9 | $7.51 | n/a | 3 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $21.00 | n/a | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $14 | $2.41 | n/a | 6 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $101 | $66.80 | n/a | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.7332 | n/a | 4 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $23 → $15 | $18.56 | n/a | 4 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $46.27 | n/a | 1 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.38 | n/a | 4 | Sep 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $23 → $14 | $10.61 | n/a | 4 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $25 | $17.18 | n/a | 2 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $26.81 | n/a | 1 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $18 | $63.30 | n/a | 6 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 | $22.51 | n/a | 1 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 → $2 | $3.40 | n/a | 3 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 → $16 | $2.45 | n/a | 2 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $80 → $150 | $543.40 | n/a | 15 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $49 | $61.62 | n/a | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 → $24 | $0.9982 | n/a | 6 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $4 | $18.88 | n/a | 5 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $62 | $1.35 | n/a | 3 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $20 | $14.78 | n/a | 2 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $7.26 | n/a | 1 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $49 → $75 | $8.36 | n/a | 10 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $0.975 | n/a | 1 | Jun 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $31.42 | n/a | 1 | Mar 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $2.30 | n/a | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $8.07 | n/a | 1 | Dec 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $18.56 | n/a | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $0.1401 | n/a | 1 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $8.06 | n/a | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $19 | $51.80 | n/a | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €80.33 | €137.60 | n/a | 1 | Feb 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 → $32 | $9.76 | n/a | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $90 → $82 | $108.62 | n/a | 15 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $13 | $3.59 | n/a | 9 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $1.87 | n/a | 2 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $9.03 | n/a | 3 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $103 → $110 | $135.13 | n/a | 11 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $2.33 | n/a | 1 | Mar 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $42.89 | $8.36 | n/a | 6 | Feb 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $80 → $105 | $223.82 | n/a | 8 | Sep 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $20 → $8 | $25.07 | n/a | 2 | Sep 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $25 → $16 | $11.52 | n/a | 2 | Oct 23, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $60 → $90 | $30.21 | n/a | 5 | Dec 2, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $12.86 | n/a | 1 | Sep 17, 2012 |
Bristol-Myers Squibb Company
Oct 13, 2026
Reiterated: Hold
Price Target: $70
Current: $56.67
Upside: +23.52%
BioNTech SE
Oct 13, 2026
Reiterated: Buy
Price Target: $125
Current: $89.01
Upside: +40.43%
Merck & Co.
Oct 13, 2026
Reiterated: Hold
Price Target: $125 → $145
Current: $141.98
Upside: +2.13%
Pfizer
Oct 13, 2026
Reiterated: Hold
Price Target: $27
Current: $28.37
Upside: -4.83%
AbbVie
Oct 12, 2026
Reiterated: Hold
Price Target: $260
Current: $274.36
Upside: -5.23%
Amgen
Oct 12, 2026
Reiterated: Hold
Price Target: $405
Current: $412.84
Upside: -1.90%
Biogen
Oct 12, 2026
Reiterated: Hold
Price Target: $215
Current: $228.90
Upside: -6.07%
Gilead Sciences
Oct 12, 2026
Reiterated: Buy
Price Target: $165
Current: $147.92
Upside: +11.55%
Eli Lilly and Company
Oct 12, 2026
Reiterated: Buy
Price Target: $1,600
Current: $1,166.51
Upside: +37.16%
Regeneron Pharmaceuticals
Oct 12, 2026
Reiterated: Hold
Price Target: $740
Current: $753.12
Upside: -1.74%
Oct 12, 2026
Reiterated: Buy
Price Target: $70
Current: $56.57
Upside: +23.74%
Oct 12, 2026
Reiterated: Buy
Price Target: $585
Current: $485.22
Upside: +20.56%
Oct 5, 2026
Reiterated: Buy
Price Target: $135 → $150
Current: $106.68
Upside: +40.61%
Oct 1, 2026
Initiated Coverage: Buy
Price Target: $325
Current: $210.39
Upside: +54.48%
Oct 1, 2026
Downgraded: Sell
Price Target: $60 → $80
Current: $216.25
Upside: -63.01%
Oct 1, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $4.72
Upside: +154.24%
Sep 15, 2026
Reiterated: Buy
Price Target: $4 → $5
Current: $1.82
Upside: +175.48%
Sep 15, 2026
Reiterated: Buy
Price Target: $160
Current: $116.26
Upside: +37.62%
Sep 14, 2026
Reiterated: Buy
Price Target: $60 → $74
Current: $40.52
Upside: +82.63%
Sep 9, 2026
Reiterated: Buy
Price Target: $182
Current: $138.49
Upside: +31.42%
Sep 9, 2026
Reiterated: Buy
Price Target: $50
Current: $19.06
Upside: +162.33%
Aug 19, 2026
Reiterated: Buy
Price Target: $26 → $32
Current: $26.85
Upside: +19.18%
Jul 29, 2026
Reiterated: Buy
Price Target: $60 → $100
Current: $78.53
Upside: +27.34%
Jul 16, 2026
Reiterated: Buy
Price Target: $55
Current: $21.51
Upside: +155.70%
May 7, 2026
Reiterated: Sell
Price Target: $7
Current: $12.82
Upside: -45.40%
May 7, 2026
Reiterated: Hold
Price Target: $75
Current: $59.92
Upside: +25.17%
Jan 30, 2026
Reiterated: Buy
Price Target: $55
Current: $20.19
Upside: +172.41%
Jun 10, 2024
Reiterated: Hold
Price Target: $170
Current: $248.61
Upside: n/a
Jun 6, 2024
Reiterated: Buy
Price Target: $22
Current: $0.3702
Upside: n/a
Jun 4, 2024
Reiterated: Buy
Price Target: $130
Current: $54.38
Upside: n/a
Jun 3, 2024
Reiterated: Buy
Price Target: $17
Current: $0.47
Upside: n/a
May 23, 2024
Reiterated: Buy
Price Target: $100
Current: $50.10
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $14 → $9
Current: $7.51
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $36
Current: $21.00
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $10 → $14
Current: $2.41
Upside: n/a
May 10, 2024
Reiterated: Buy
Price Target: $101
Current: $66.80
Upside: n/a
Mar 15, 2024
Rated: Hold
Price Target: n/a
Current: $0.7332
Upside: n/a
Dec 15, 2023
Downgraded: Hold
Price Target: $23 → $15
Current: $18.56
Upside: n/a
Oct 11, 2023
Reiterated: Sell
Price Target: n/a
Current: $46.27
Upside: n/a
Sep 29, 2023
Rated: Hold
Price Target: n/a
Current: $1.38
Upside: n/a
Sep 8, 2023
Downgraded: Hold
Price Target: $23 → $14
Current: $10.61
Upside: n/a
Jul 18, 2023
Reiterated: Buy
Price Target: $35 → $25
Current: $17.18
Upside: n/a
Mar 16, 2023
Reiterated: Buy
Price Target: $13
Current: $26.81
Upside: n/a
Mar 6, 2023
Reiterated: Buy
Price Target: $13 → $18
Current: $63.30
Upside: n/a
Feb 28, 2023
Reiterated: Hold
Price Target: $23
Current: $22.51
Upside: n/a
Feb 23, 2023
Downgraded: Sell
Price Target: $8 → $2
Current: $3.40
Upside: n/a
Feb 22, 2023
Reiterated: Hold
Price Target: $15 → $16
Current: $2.45
Upside: n/a
Feb 22, 2023
Reiterated: Sell
Price Target: $80 → $150
Current: $543.40
Upside: n/a
Feb 17, 2023
Initiated Coverage: Hold
Price Target: $49
Current: $61.62
Upside: n/a
Feb 16, 2023
Reiterated: Sell
Price Target: $2 → $24
Current: $0.9982
Upside: n/a
Jun 8, 2022
Downgraded: Hold
Price Target: $12 → $4
Current: $18.88
Upside: n/a
May 18, 2022
Reiterated: Buy
Price Target: $75 → $62
Current: $1.35
Upside: n/a
May 17, 2022
Reiterated: Buy
Price Target: $28 → $20
Current: $14.78
Upside: n/a
Jan 13, 2022
Reiterated: Buy
Price Target: $60
Current: $7.26
Upside: n/a
Oct 8, 2021
Reiterated: Hold
Price Target: $49 → $75
Current: $8.36
Upside: n/a
Jun 8, 2021
Upgraded: Hold
Price Target: n/a
Current: $0.975
Upside: n/a
Mar 19, 2021
Reiterated: Buy
Price Target: $35
Current: $31.42
Upside: n/a
Jan 5, 2021
Reiterated: Buy
Price Target: $70
Current: $2.30
Upside: n/a
Dec 7, 2020
Reiterated: Buy
Price Target: $9
Current: $8.07
Upside: n/a
Nov 23, 2020
Initiated Coverage: Buy
Price Target: $21
Current: $18.56
Upside: n/a
Sep 8, 2020
Initiated Coverage: Buy
Price Target: $20
Current: $0.1401
Upside: n/a
Jun 25, 2020
Initiated Coverage: Buy
Price Target: $30
Current: $8.06
Upside: n/a
Feb 25, 2020
Downgraded: Hold
Price Target: $20 → $19
Current: $51.80
Upside: n/a
Feb 20, 2020
Reiterated: Hold
Price Target: €80.33
Current: €137.60
Upside: n/a
Dec 3, 2019
Initiated Coverage: Buy
Price Target: $27 → $32
Current: $9.76
Upside: n/a
May 3, 2019
Downgraded: Hold
Price Target: $90 → $82
Current: $108.62
Upside: n/a
May 2, 2019
Reiterated: Hold
Price Target: $13 → $13
Current: $3.59
Upside: n/a
Mar 29, 2019
Reiterated: Buy
Price Target: $27
Current: $1.87
Upside: n/a
Mar 29, 2019
Reiterated: Hold
Price Target: $8
Current: $9.03
Upside: n/a
Mar 28, 2019
Reiterated: Buy
Price Target: $103 → $110
Current: $135.13
Upside: n/a
Mar 11, 2019
Initiated Coverage: Buy
Price Target: $16
Current: $2.33
Upside: n/a
Feb 20, 2019
Rated: Buy
Price Target: $42.89
Current: $8.36
Upside: n/a
Sep 7, 2017
Rated: Buy
Price Target: $80 → $105
Current: $223.82
Upside: n/a
Sep 7, 2017
Rated: Sell
Price Target: $20 → $8
Current: $25.07
Upside: n/a
Oct 23, 2015
Downgraded: Sell
Price Target: $25 → $16
Current: $11.52
Upside: n/a
Dec 2, 2014
Downgraded: Hold
Price Target: $60 → $90
Current: $30.21
Upside: n/a
Sep 17, 2012
Downgraded: Hold
Price Target: n/a
Current: $12.86
Upside: n/a